Diabetes Warning Issued for Statin Drugs

A class of drugs called statins lowers blood cholesterol levels by reducing the production of cholesterol by the liver. Lipid regulators, which are primarily statin drugs, are the most commonly prescribed medication in the U.S., according to a report by the IMS Institute for Healthcare Informatics.

Last month the FDA acknowledged that statins may play a role in elevated blood sugar, as well as memory and cognition problems. It determined that the increased risk of diabetes was sufficient to warrant a warning on statin labels.

Although cholesterol is essential to normal cellular function, it also contributes to the development of atherosclerosis, a condition in which cholesterol-containing plaques form within arteries. They can become blood clots and cause angina (chest pain) and heart attacks. If the clot occurs in the brain, the result is a stroke.

Statins are prescribed to prevent and treat atherosclerosis. The most common statin brands are Liptor, Lescol, Mevacor, Crestor, Socor and Pravacahol, among others. They can save lives, but, as always with prescription medicine, are not without risk.

Please see full article below for more information.

LOADING PDF: If there are any problems, click here to download the file.

Written by:

Published In:

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Patrick Malone & Associates P.C. | DC Injury Lawyers | Attorney Advertising

Don't miss a thing! Build a custom news brief:

Read fresh new writing on compliance, cybersecurity, Dodd-Frank, whistleblowers, social media, hiring & firing, patent reform, the NLRB, Obamacare, the SEC…

…or whatever matters the most to you. Follow authors, firms, and topics on JD Supra.

Create your news brief now - it's free and easy »

All the intelligence you need, in one easy email:

Great! Your first step to building an email digest of JD Supra authors and topics. Log in with LinkedIn so we can start sending your digest...

Sign up for your custom alerts now, using LinkedIn ›

* With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name.
×
Loading...
×
×